MIF and cancer: Emerging evidence suggests that MASLD induces a pro-tumorigenic microenvironment characterized by immunosuppression, increased fibrosis, and alterations in tumor cell behavior.16 These changes may be mediated by hepatic secreted factors, such as the MIF, a multifunctional cytokine with established roles in inflammation and cancer progression.